KalVista Pharmaceuticals, Inc. Common Stock (KALV) News
Latest headlines that mention KALV, newest first · each headline opens the original publisher
- Last price
- $27.00
- Day change
- +0.04%
- Next earnings
- —
KALV headlines
latest coverageNot much coverage yet. KALV has appeared in only a few headlines lately; new stories show up here as publishers cover it.
This clinical-stage biotech focused on rare diseases reported a notable insider sale amid a year of strong stock performance.
KALV news alerts
Get an alert by email or push when a new headline mentions KALV.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.